Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

Ohio Third Frontier (OTF), Ohio Development Services Agency

The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:

Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.

Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.

The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.

Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or mhaag@case.edu.

For more information on the TVSF visit the Ohio Third Frontier website.

 

CDC: Economic Studies of Immunization Policies and Practices

Funding Opportunity Number: RFA-IP-15-001

The purpose of this Funding Opportunity Announcement is to obtain economic information about vaccines and immunization policies, programs, and practices using economic and decision analyses and other appropriate methods. The results of these economic studies will be used to help inform policy and the development of effective interventions. Three studies will be conducted, including an analysis of the financial, economic, and epidemiologic relationships between vaccine-preventable infectious diseases and chronic diseases in adult populations, and the opportunity costs for immunization of failure to prevent chronic diseases. Study 1 may include, but need not be limited to influenza and pneumococcal diseases and diabetes. Study 2 will focus on an estimation of the costs of norovirus disease. Study three will involve an analysis of issues related to provider reimbursement for adult vaccination services.

Application Deadline: March 3, 2015

For more information visit the CDC’s Full Funding Opportunity Announcement.

 
National Endowment for the Humanities (NEH)

The National Endowment for the Humanities has announced a new grant opportunity that encourages the publication of nonfiction books that apply serious humanities scholarship to subjects of general interest and appeal.

The new NEH Public Scholar awards support well-researched books in the humanities conceived and written to reach a broad readership. Books supported through this program might present a narrative history, tell the stories of important individuals, analyze significant texts, provide a synthesis of ideas, revive interest in a neglected subject, or examine the latest thinking on a topic. Most importantly, they should open up important and appealing subjects for wider audiences by presenting significant humanities topics in a way that is accessible to general readers.

The Public Scholar program is open to both independent scholars and individuals affiliated with scholarly institutions. It offers a stipend of $4,200 per month for a period of six to twelve months. The maximum stipend is $50,400 for a twelve-month period. Applicants must have previously published a book or monograph with a university or commercial press, or articles and essays that reach a wide readership.

Application Deadline for first cycle: March 3, 2015 For more information visit the NEH website.

 
NEW Limited Submission: American Diabetes Association Pathway to Stop Diabetes

Key Deadlines: March 2, 2015, 5:00pm (CWRU Internal Submission Deadline), July 1, 2015, 8:00pm EST.

To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association has launched a bold initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, treatment and cures.

Pathway will support creative scientists early in their diabetes research careers, or investigators who are established in other disciplines but would like to expand their focus to diabetes research. Through awards of $1.625 million over the course of up to seven years, the program will provide researchers the freedom, autonomy, time and focus needed to explore new ideas.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)

The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle.

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati

Letter of Intent Deadline: February 10, 2015

For more information visit the NCAI-CC website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.